Search research articles
Contact Us
Filters
Showing results (31-40 of 77) with videos related to
Page
of 8
Sort By:
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Evolutionary antifragile therapy
Jeffrey West, Bina Desai, Maximilian Strobl, et al.
Scientific Reports
|
April 29, 2017
Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer
Andrew Dhawan, Daniel Nichol, Fumi Kinose, et al.
Medical Oncology (Northwood, London, England)
|
July 5, 2022
Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes
Jason A Somarelli, James DeGregori, Marco Gerlinger, et al.
Cancer Research
|
May 22, 2026
Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexity
Jeffrey West, Bina Desai, Maximilian A R Strobl, et al.
Evolution, Medicine, and Public Health
|
December 11, 2024
Towards a new therapeutic approach based on selection for function in tumors: response to Dr. Mesut Tez
Frédéric Thomas, James DeGregori, Andriy Marusyk, et al.
Evolution, Medicine, and Public Health
|
October 4, 2024
A new perspective on tumor progression: Evolution via selection for function
Frédéric Thomas, James DeGregori, Andriy Marusyk, et al.
Science Advances
|
July 1, 2022
Measuring competitive exclusion in non-small cell lung cancer
Nathan Farrokhian, Jeff Maltas, Mina Dinh, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cycles
Daria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Cancer Research
|
October 4, 2023
Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy Cycles
Daria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Mathematical Medicine and Biology : a Journal of the IMA
|
February 17, 2018
Simulated ablation for detection of cells impacting paracrine signalling in histology analysis
Jake P Taylor-King, Etienne Baratchart, Andrew Dhawan, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 77) with videos related to
Sort By:
Page
of 8
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Evolutionary antifragile therapy
Jeffrey West, Bina Desai, Maximilian Strobl, et al.
Scientific Reports
|
April 29, 2017
Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer
Andrew Dhawan, Daniel Nichol, Fumi Kinose, et al.
Medical Oncology (Northwood, London, England)
|
July 5, 2022
Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes
Jason A Somarelli, James DeGregori, Marco Gerlinger, et al.
Cancer Research
|
May 22, 2026
Evolutionary antifragile therapy is a treatment strategy to suppress drug resistance by exploiting dose response convexity
Jeffrey West, Bina Desai, Maximilian A R Strobl, et al.
Evolution, Medicine, and Public Health
|
December 11, 2024
Towards a new therapeutic approach based on selection for function in tumors: response to Dr. Mesut Tez
Frédéric Thomas, James DeGregori, Andriy Marusyk, et al.
Evolution, Medicine, and Public Health
|
October 4, 2024
A new perspective on tumor progression: Evolution via selection for function
Frédéric Thomas, James DeGregori, Andriy Marusyk, et al.
Science Advances
|
July 1, 2022
Measuring competitive exclusion in non-small cell lung cancer
Nathan Farrokhian, Jeff Maltas, Mina Dinh, et al.
Biorxiv : the Preprint Server for Biology
|
February 17, 2023
Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cycles
Daria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Cancer Research
|
October 4, 2023
Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy Cycles
Daria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.
Mathematical Medicine and Biology : a Journal of the IMA
|
February 17, 2018
Simulated ablation for detection of cells impacting paracrine signalling in histology analysis
Jake P Taylor-King, Etienne Baratchart, Andrew Dhawan, et al.
Page
of 8